Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Lithium Universe LtdInterview with Executive Chairman July 5, 2025 Quimbaya Gold Closes $4 Million Financing and Expands Executive Team July 5, 2025 Syntheia Signs Definitive Agreement for Call Center Acquisition July 5, 2025